Elkfork Partners’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
$21.1M Sell
311,920
-18,088
-5% -$1.19M 0.51% 46
2019
Q2
$21.9M Sell
330,008
-14,196
-4% -$827K 0.54% 45
2019
Q1
$19.1M Buy
344,204
+58,884
+21% +$3.59M 0.48% 53
2018
Q4
$14.1M Buy
285,320
+1,008
+0.4% +$61.7K 0.4% 59
2018
Q3
$24.6M Buy
284,312
+187,712
+194% +$13.4M 0.58% 39
2018
Q2
$5.61M Sell
96,600
-13,160
-12% -$643K 0.14% 149
2018
Q1
$4.42M Buy
109,760
+12,292
+13% +$464K 0.12% 168
2017
Q4
$3.4M Sell
97,468
-12,124
-11% -$403K 0.09% 185
2017
Q3
$3.63M Buy
109,592
+5,600
+5% +$184K 0.11% 173
2017
Q2
$3.61M Sell
103,992
-16,800
-14% -$490K 0.11% 166
2017
Q1
$3.02M Hold
120,792
0.09% 188
2016
Q4
$1.99M Buy
+120,792
New +$2.05M 0.07% 219

Other funds holding TDOC

Elkfork Partners's TDOC Position: Q3 2019 in Review

Elkfork Partners reduced its Teladoc Health (TDOC) stake by 5.5% in Q3 2019, selling an estimated $1.19M and leaving 311,920 shares worth $21.1M. The position accounts for 0.51% of the portfolio, ranked #46.

Elkfork Partners first reported a position in TDOC in Q4 2016 and has held it in 12 quarters since. The position peaked at $24.6M in Q3 2018. 377 funds tracked by Wall St. Rank hold TDOC as of Q3 2019.

  • Elkfork Partners held 311,920 shares of Teladoc Health worth $21.1M as of Q3 2019.
  • Elkfork Partners sold 18,088 Teladoc Health shares in Q3 2019, an estimated $1.19M.
  • Teladoc Health made up 0.51% of Elkfork Partners's portfolio in Q3 2019, its #46 holding.
  • Elkfork Partners first reported a position in Teladoc Health in Q4 2016 and has held it in 12 quarters since.
  • Elkfork Partners's Teladoc Health position peaked at $24.6M in Q3 2018.
  • 377 funds tracked by Wall St. Rank held Teladoc Health as of Q3 2019.

Based on Elkfork Partners's 13F filing for Q3 2019, filed 14 Nov 2019.